Hydroxychloroquine
-
Subject Areas on Research
- 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.
- 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
- A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
- Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide.
- Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
- Breastfeeding in mothers with systemic lupus erythematosus.
- Bullous systemic lupus erythematosus in a 6-year-old boy.
- Cardiac manifestations of Q fever infection: case series and a review of the literature.
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
- Controversies in the Management of Isolated Congenital Atrioventricular Block.
- Delivering clinical trials at home: protocol, design and implementation of a direct-to-family paediatric lupus trial.
- Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of the Extent of and Reasons for Medication Nonadherence.
- Dr. Balevic, et al reply.
- Early-Onset Hydroxychloroquine Retinopathy and a Possible Relationship to Blood Levels: Comment on the Article by Petri et al.
- Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
- Effect of pregnancy on disease flares in patients with systemic lupus erythematosus.
- Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
- Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients.
- Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus: Evaluating Similarities in Exposure-Response.
- Fatal Cerebral Edema in a Child With COVID-19.
- Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.
- Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.
- Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes.
- Hydroxychloroquine and COVID-19: a Rheumatologist's Take on the Lessons Learned.
- Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
- Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation.
- Hydroxychloroquine for COVID-19: Variation in Regional Political Preferences Predicted New Prescriptions after President Trump's Endorsement.
- Hydroxychloroquine for Non-Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ).
- Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials.
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.
- Hydroxychloroquine in lupus pregnancy.
- Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data.
- Hydroxychloroquine retinopathy: screening needed to prevent blindness.
- Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
- Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
- Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
- Hydroxychloroquine: a treatable cause of cardiomyopathy.
- Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
- Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.
- Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents.
- Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
- Ocular findings in Japanese patients with hydroxychloroquine retinopathy developing within 3 years of treatment.
- Pharmacokinetics of Hydroxychloroquine in Pregnancies with Rheumatic Diseases.
- Pharmacokinetics of hydroxychloroquine in paediatric lupus: data from a novel, direct-to-family clinical trial.
- Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.
- Progress in the treatment of rheumatoid arthritis.
- Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.
- Rationale and Design of the COVID-19 Outpatient Prevention Evaluation (COPE - Coalition V) Randomized Clinical Trial: Hydroxychloroquine vs. Placebo in Non-Hospitalized Patients.
- Reasons for cesarean and medically indicated deliveries in pregnancies in women with systemic lupus erythematosus.
- Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users.
- Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.
- Reply to abnormalities on the multifocal electroretinogram may precede clinical signs of hydroxychloroquine retinotoxicity.
- Reply: To PMID 23218706.
- Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.
- Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
- Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.
- Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.
- Solving the Hydroxychloroquine Dosing Dilemma With a Smartphone App.
- Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature.
- The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing Both.
- Trial of Early Antiviral Therapies during Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19: a summary of the protocol and analysis plan for a decentralized randomized controlled trial.
- Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
-
Keywords of People
- Schanberg, Laura Eve, Professor of Pediatrics, Pediatrics, Rheumatology